Publication | Closed Access

Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial

VaccinationVaccine SafetyUrologyVaccine EfficacyPlacebo-controlled Phase 1BInfection ControlMedicineClinical MicrobiologyPreliminary Clinical Efficacy